By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862


SEARCH JOBS


Industry
Biotechnology






Company News
Antibe Therapeutics (ATE.V) Enters Into Regional Licensing Deal 2/24/2017 9:22:24 AM
Antibe Therapeutics (ATE.V) Engages MKR Group For U.S. Investor Relations 2/21/2017 6:29:55 AM
Antibe Therapeutics (ATE.V) Announces The Launch Of PentOS OI Max, Its Newest Bone Graft Substitute For Oral And Maxillofacial Surgery 1/31/2017 11:11:05 AM
Antibe Therapeutics (ATE.V) Release: Biotech Announces Change Of Auditor To Ernst & Young LLP 1/19/2017 8:25:42 AM
Antibe Therapeutics (ATE.V) Completes Final Closing Of Private Placement Bringing Total Proceeds To $2.7 Million 12/22/2016 10:34:40 AM
Antibe Therapeutics (ATE.V) Raises $2.4 Million In First Tranche Of Private Placement 12/16/2016 11:43:18 AM
Antibe Therapeutics (ATE.V) Reports Q2 2017 Interim Financial And Operating Results 11/30/2016 11:17:34 AM
Antibe Therapeutics (ATE.V) Announces Payment In Kind Election 10/17/2016 1:21:38 PM
Antibe Therapeutics (ATE.V) Confirms Non-Addictive Properties For Its Second Pipeline Drug, ATB-352, A Potent, Non-Addictive Pain-Killer 10/17/2016 1:10:42 PM
Antibe Therapeutics (ATE.V) Announces Launch Of Strategic Growth Initiative In The U.S. Market For Dental Biologics 10/11/2016 11:01:09 AM
12345678
//-->